HighRAD

An oncology AI imaging platform for quantitative, multi-organ analysis of disease progression and treatment efficacy.

Health Tech & Life Sciences
Active
Seed Tel Aviv, Israel Founded 2019
Last updated 2026-07-26
Total raised
Last: Undisclosed Round 2021-01
Stage
Seed
Founded
2019
Headcount
7
HQ
Tel Aviv, Israel
Sector
Health Tech & Life Sciences

About

HighRAD is an Israeli startup that provides an innovative FDA-cleared oncology AI imaging platform. The platform offers fully automated, quantitative, and comparative analysis for evaluating disease progression and treatment efficacy across multiple organs. HighRAD's solutions, such as iCAS-LV, iCAS-LG, and iCAS-BR, are designed around a novel Region of Difference (ROD) generic platform for analyzing lesion changes in longitudinal volumetric scans like CT and MRI. HighRAD's technology enhances disease understanding and improves treatment outcomes, boosting radiologist productivity for quicker, more confident diagnoses. Their system offers seamless connectivity, integrating with all CT, MRI, and PET systems, and is adaptable to various clinical protocols. HighRAD's iCAS-LV product received FDA clearance in March 2024.

Funding history · 1 round · — total

2020-12
Undisclosed Round Undisclosed
★ Integra Holdings

Headcount over time

From 2 (2020-02) to 7 (2025-12) · +5 (+250%) · 12 points · source: Finder history + radar grounding
110 2020-02 2025-12

Q&A

What is HighRAD's primary focus?
HighRAD is an Israeli startup that provides an FDA-cleared oncology AI imaging platform for quantitative, multi-organ analysis of disease progression and treatment efficacy.
When was HighRAD founded?
HighRAD was founded in October 2019.
What is HighRAD's employee count?
HighRAD has 7 employees, falling within the 1-10 employee bucket.
What is the total amount of funding HighRAD has raised?
HighRAD has raised a total of $215,000.
When did HighRAD receive FDA clearance for its iCAS-LV product?
HighRAD's iCAS-LV product received FDA clearance in March 2024.
Which investor participated in HighRAD's Seed round in April 2026?
ILIOS 72 Alternative Capital participated in HighRAD's Seed round in April 2026.
What is HighRAD's current funding stage?
HighRAD is currently in the Seed funding stage.
Who are the co-founders of HighRAD?
The co-founders of HighRAD are Prof. Leo Joskowicz (Co-Founder & CTO) and Prof. Jacob Sosna (Co-Founder, CMO & Chairman, SAB).

Team · 2

Prof. Leo Joskowicz
Founder · Co-Founder & CTO
Prof. Jacob Sosna
Founder · Co-Founder, CMO & Chairman, SAB

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesDigital HealthcareMedical Decision Support
Technologies
Artificial IntelligenceComputer VisionImage RecognitionPlatforms & InterfacesWeb
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2B

Tags

artificial-intelligencedigital-healthcaredecision-support
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

Websitehigh-rad.com
LinkedInlinkedin.com/company/64601242
Facebookfacebook.com/Highrad-Ltd-112305246972386

Identifiers & details

Legal nameHighRad Ltd.
Founded2019-10
Employees (exact)7

Radar intelligence

Patents

EPO1

Web history (Wayback)

Domainhigh-rad.com

Certificate / subdomain footprint

Subdomains1

Israeli Companies Registrar (רשם החברות / ICA)

Registrar # (ח.פ.)516124427
Statusפעילה
Corp typeישראלית חברה פרטית
Incorporated2019-12-25
Purposeלעסוק בכל עיסוק חוקי
Liabilityמוגבלת
In violation (unfiled)yes
Last annual report2022
Active charges / liens0
Registry events0
Registered addressדרך בגין 132 תל אביב - יפו